» Articles » PMID: 17999583

Efficacy of a Pneumonia Prevention Protocol in the Reduction of Ventilator-associated Pneumonia in Trauma Patients

Overview
Date 2007 Nov 15
PMID 17999583
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We hypothesized that implementing evidence-based ventilator-associated pneumonia (VAP) prevention (VAPP) strategies would decrease the incidence of VAP, and that VAP affects patient outcomes.

Methods: A prospective study was performed with 331 consecutive ventilated trauma patients in a level one university teaching hospital. The VAPP protocol was modified to include elevation of the head of the bed more than 30 degrees , twice-daily chlorhexidine oral cleansing, a once-daily respiratory therapy-driven weaning attempt, and conversion from a nasogastric to an orogastric tube whenever possible. Ventilator days were compared with occurrences of nosocomial pneumonia, as defined by the U.S. Centers for Disease Control National Nosocomial Infection Surveillance criteria. Patients with and without VAP were compared to discern the effect VAP has on outcome.

Results: In 2003, there were 1,600 days of ventilator support with 11 occurrences of VAP (6.9/1,000 ventilator days). In 2004, there were two occurrences of VAP in 703 days of ventilation (2.8/1,000 ventilator days). In the analysis of outcomes of the patients with and without VAP, there was a statistically significant difference in total hospital days (38.7 +/- 26.2 vs. 13.3 +/- 15.5), ICU days (27.8 +/- 12.6 vs. 7.5 +/- 9.7), ventilator days (21.1 +/- 9.8 vs. 6.0 +/- 10.3), Functional Independence Measures (7.25 +/- 2.3 vs. 10.8 +/- 1.8), and hospital charges ($371,416.70 +/- $227,774.31 vs. $138,317.39 +/- $208,346.64)(p < 0.05 for all). The mortality rate did not decrease significantly (20% vs. 7.5%; p = NS). The difference in the mean Injury Severity Score in the two groups was not significant (21.9 +/- 9.6 vs. 16.7 +/- 11.4 points) and thus could not account for the differences in outcomes.

Conclusion: These data suggest that a VAPP protocol may reduce VAP in trauma patients. Ventilator-associated pneumonia may result in more hospital, ICU, and ventilator days and higher patient charges.

Citing Articles

Prevention of ventilator-associated pneumonia through care bundles: A systematic review and meta-analysis.

Martinez-Reviejo R, Tejada S, Jansson M, Ruiz-Spinelli A, Ramirez-Estrada S, Ege D J Intensive Med. 2023; 3(4):352-364.

PMID: 38028633 PMC: 10658042. DOI: 10.1016/j.jointm.2023.04.004.


An Ounce of Prevention Saves Tons of Lives: Infection in Burns.

Merchant N, Smith K, Jeschke M Surg Infect (Larchmt). 2015; 16(4):380-7.

PMID: 26207399 PMC: 4523002. DOI: 10.1089/sur.2013.135.


International multidisciplinary consensus conference on multimodality monitoring: ICU processes of care.

McNett M, Horowitz D Neurocrit Care. 2014; 21 Suppl 2:S215-28.

PMID: 25208666 DOI: 10.1007/s12028-014-0020-x.


Prevention of ventilator-associated pneumonia in the intensive care unit: a review of the clinically relevant recent advancements.

Keyt H, Faverio P, Restrepo M Indian J Med Res. 2014; 139(6):814-21.

PMID: 25109715 PMC: 4164993.


Clinical practice guidelines in the AANS/CNS Section on Tumors: past, present and future directions.

Linskey M, Olson J, Mitchell L, Kalkanis S J Neurooncol. 2014; 119(3):557-68.

PMID: 25081972 DOI: 10.1007/s11060-014-1497-z.